Beranda › Kanker Ovarium › California › Santa Monica
Uji klinis Kanker Ovarium di Santa Monica, CA
15 studi untuk Kanker Ovarium mencari peserta di lokasi sekitar Santa Monica (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Menerima pesertaFase 2
- Saint John's Cancer Institute, Santa Monica
A Study of PHST001 in Advanced Solid Tumors
Menerima pesertaFase 1
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi jauhnya
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Menerima pesertaFase 1
- Research Site, Santa Monica
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Menerima pesertaStudi observasional
- UCLA Medical Center, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Kivu Trial Site, Santa Monica
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Menerima pesertaFase 1
- UCLA Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · 6 mi jauhnya
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Menerima pesertaFase 1/2
- Research Site, Santa Monica
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Menerima pesertaFase 3
- Site 0104, Beverly Hills · 6 mi jauhnya
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Menerima peserta
- Tower Cancer Research Foundation, Beverly Hills · 6 mi jauhnya
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi jauhnya
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Menerima pesertaFase 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · 4 mi jauhnya
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi jauhnya
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Menerima pesertaFase 1
- UCLA Department of Medicine - Hematology & Oncology, Santa Monica
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Menerima pesertaFase 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Menerima pesertaFase 1
- University of California, Los Angeles, Santa Monica
A Beta-only IL-2 ImmunoTherapY Study
Menerima pesertaFase 1/2
- Providence Saint John's Health Center, Santa Monica
Uji klinis Kanker Ovarium di kota lain
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Studi lain di Santa Monica
- Kanker Paru Non-Sel Kecil45 studi
- Kanker Payudara28 studi
- Kanker Kolorektal23 studi
- Kanker (semua jenis)22 studi
- Kanker Metastatik19 studi
- Kanker Paru15 studi
- Kanker Prostat15 studi
- Karsinoma Sel Skuamosa Kepala dan Leher13 studi
- Gagal Jantung11 studi
- Kanker Endometrium10 studi
- Kanker Lambung9 studi
- Kanker Pankreas9 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.